Attention recruitment agencies: All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. The 4DMT Talent Acquisition team must expressly engage agencies on any requisition. Agencies contacting hiring managers directly will not be tolerated, and doing so may impact your ability to work with 4DMT in the future.

4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. The Company’s lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF biologics (aflibercept and anti-VEGF-C) with a single intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. The Company’s lead indication for 4D-150 is wet age-related macular degeneration and the second indication is diabetic macular edema, which are both in Phase 3 development. The Company’s second product candidate is 4D-710, which is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery.

We are taking genetic medicine to new heights and into new disease areas to overcome challenges not addressed by existing medicines. This incredible challenge drives our relentless and talented team. Our people are the essence of our inspiring, innovative and collaborative environment that encourages individual contributions and provides opportunities for career development. We seek the best in the industry who identify with our mission and our bold and innovative results-driven approach. Our Core Values drive the way we work together:

Dare to Cure
Break Boundaries
Beyond Yourself
Prepare & Execute Relentlessly

Join us in creating the future of genetic medicine.

GENERAL SUMMARY

The Executive Director of Statistical Programming will provide strategic and operational leadership for statistical programming across assigned development programs. The role will apply deep programming expertise to guide in-house deliverables, ensure rigorous quality review of outsourced statistical deliverables, and establish scalable standards and processes. They will serve as a senior member of cross-functional teams, partnering with Biostatistics, Data Management, Clinical Development, Regulatory, Clinical Operations, Quality, IT, and external vendors to plan, prioritize, and execute activities supporting program and organizational objectives.

MAJOR DUTIES & RESPONSIBILITIES

Provide strategic and operational statistical programming leadership for assigned indications and development programs that may consist of multiple clinical trials and submission deliverables
Partner closely with biostatisticians and cross-functional stakeholders to review statistical analysis plans and ensure development of clear, fit-for-purpose data and analysis programming specifications
Ensure complete, auditable, and inspection-ready programming documentation for clinical trial analyses and regulatory submissions
Lead the development, governance, documentation, and maintenance of reusable programming code, standards, templates, and best practices
Partner with IT and functional leadership to define and maintain fit-for-purpose statistical computing infrastructure, including the SAS server environment and related tools
Provide senior statistical programming expertise and, as needed, biometrics leadership on select projects and cross-functional initiatives
Collaborate with various functions to ensure robust CRF/EDC development, and quality data collection for the assigned clinical trials
Oversee biometrics vendors and external programming partners to ensure timely, high-quality statistical deliverables, effective issue escalation, and clear accountability
Ensure quality review of outsourced statistical deliverables, including in-house double programming or quality control as needed, and coordinate internal review comments and resolution